136 related articles for article (PubMed ID: 27261177)
1. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.
Zhang S; Vue B; Huang M; Zhang X; Lee T; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3226-3231. PubMed ID: 27261177
[TBL] [Abstract][Full Text] [Related]
2. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
[TBL] [Abstract][Full Text] [Related]
3. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.
Vue B; Zhang X; Lee T; Nair N; Zhang S; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4845-4854. PubMed ID: 28756013
[TBL] [Abstract][Full Text] [Related]
4. 7-O-aminoalkyl-2,3-dehydrosilibinins: Synthesis and in vitro Anti-cancer Efficacy.
Ma DY; Zhang LC; Peng KJ; Zeng J; Liu LJ; Luo ZY; Liu SY
Anticancer Agents Med Chem; 2018; 18(8):1156-1162. PubMed ID: 29607789
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
[TBL] [Abstract][Full Text] [Related]
6. 3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
Li X; Lee M; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4768-4777. PubMed ID: 28760528
[TBL] [Abstract][Full Text] [Related]
7.
Vue B; Zhang S; Vignau A; Chen G; Zhang X; Diaz W; Zhang Q; Zheng S; Wang G; Chen QH
Molecules; 2018 Nov; 23(12):. PubMed ID: 30501133
[TBL] [Abstract][Full Text] [Related]
8. 3-
Wu S; Chen G; Zhang Q; Wang G; Chen QH
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770829
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
[TBL] [Abstract][Full Text] [Related]
10. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
Flaig TW; Su LJ; Harrison G; Agarwal R; Glodé LM
Int J Cancer; 2007 May; 120(9):2028-33. PubMed ID: 17230508
[TBL] [Abstract][Full Text] [Related]
11. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
Li X; Chen G; Zhang X; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Sep; 26(17):4241-5. PubMed ID: 27476422
[TBL] [Abstract][Full Text] [Related]
12. Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models.
Rajaram P; Jiang Z; Chen G; Rivera A; Phasakda A; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Chem; 2019 Jun; 87():227-239. PubMed ID: 30904813
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.
Zhang X; Guo S; Chen C; Perez GR; Zhang C; Patanapongpibul M; Subrahmanyam N; Wang R; Keith J; Chen G; Dong Y; Zhang Q; Zhong Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2017 Sep; 137():263-279. PubMed ID: 28601720
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
16. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
Li X; Zhang C; Guo S; Rajaram P; Lee M; Chen G; Fong R; Gonzalez A; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2018 Sep; 157():978-993. PubMed ID: 30165345
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of substituted aminopyridazin-3(2H)-ones as G0/G1-phase arresting agents with apoptosis-inducing activities.
Ge BC; Feng HF; Cheng YF; Wang HT; Xi BM; Yang XM; Xu JP; Zhou ZZ
Eur J Med Chem; 2017 Dec; 141():440-445. PubMed ID: 29040954
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin.
Antoszczak M; Klejborowska G; Kruszyk M; Maj E; Wietrzyk J; Huczyński A
Chem Biol Drug Des; 2015 Dec; 86(6):1378-86. PubMed ID: 26058448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
